ID   H21F8-1
AC   CVCL_L519
SY   1F8
DR   CLO; CLO_0003589
DR   ATCC; CRL-8018
DR   BCRC; 60234
DR   Wikidata; Q54872016
RX   Patent=US4271145;
RX   Patent=US4870026;
RX   PubMed=6940137;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8018.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Hepatitis B virus HBsAG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
RX   Patent=US4271145;
RA   Wands J.R., Zurawski V.R. Jr.;
RT   "Process for producing antibodies to hepatitis virus and cell lines
RT   therefor.";
RL   Patent number US4271145, 02-Jun-1981.
//
RX   Patent=US4870026;
RA   Wands J.R., Shafritz D.A.;
RT   "Non-A, non-B. hepatitis, virus, methods of identification
RT   purification, characterization, diagnosis and immunization.";
RL   Patent number US4870026, 26-Sep-1989.
//
RX   PubMed=6940137; DOI=10.1073/pnas.78.2.1214;
RA   Wands J.R., Carlson R.I., Schoemaker H.J.P., Isselbacher K.J.,
RA   Zurawski V.R. Jr.;
RT   "Immunodiagnosis of hepatitis B with high-affinity IgM monoclonal
RT   antibodies.";
RL   Proc. Natl. Acad. Sci. U.S.A. 78:1214-1218(1981).
//